Post Type Archives: News

This expands ESTEVE’s portfolio of medications for rare and severe diseases with three products to treat Cushing’s syndrome and adrenocortical carcinoma; and drives its international growth.   ESTEVE has completed the acquisition of HRA Pharma Rare Diseases, a business specialized in rare diseases, from Perrigo Company plc. With this acquisition, ESTEVE expands its portfolio in […]

Nordic Group B.V., an international pharmaceutical company operating as Nordic Pharma, announced that Lacrifill®, a novel therapy for dry eye, has just received CE mark approval. This significant regulatory milestone achieved several months ahead of schedule, allows Nordic Pharma to introduce Lacrifill® across European markets, with a planned launch in the coming months. Lacrifill® is […]

Indena is the Italian leading company dedicated to the identification, development and production of high-quality active principles derived from plants, for use in the pharmaceutical and health food industries. It will be part of CPHI Japan from 9 to 11 April, at East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, booth IT 16. […]

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Administration (FDA) inspection for its Unit-2 facility in Raichur, India, with no 483 observations. This marks the second consecutive clean inspection at the facility, with the FDA conducting the audit from March 10-14. This […]

Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), today announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery that offer a promising approach to combat respiratory diseases. Room-temperature stability aims to […]

Veranova is proud to announce the appointment of Dr. Scott Zugel as Global Vice President of Analytical Research Development Operations. Dr. Zugel brings 25 years of experience in the chemical and pharmaceutical industries, with extensive expertise in the analytical development of both small and large molecules. He is well-versed in the development and validation of […]

Tjoapack, a leading, global contract packaging organization, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients. The new tool enhances efficiency and transparency in artwork management, file exchange, workflow creation, and order management, reinforcing Tjoapack’s commitment to providing seamless, customer-centric solutions. The […]

Meitheal Pharmaceuticals, Inc., a fully integrated biopharmaceutical company based in Chicago focused on the development and commercialization of generic injectables, fertility, biologic, and branded products, today announced it has received U.S. Food and Drug Administration (FDA) approval for and launched liraglutide injection (18mg/3mL), its generic equivalent for Victoza®2 in the U.S. Liraglutide injection is a glucagon-like […]

Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy Previous divisional structure is now replaced with three newly formed CDMO Business Platforms: Integrated Biologics, Advanced Synthesis, and Specialized Modalities The model comes into effect today, and is reflected on the updated Lonza.com website Lonza has announced that its […]

High Force Research, a leading provider of specialist chemical R&D and manufacturing services, has announced the appointment of Dr Nathalie Huther as its new Chief Commercial Officer (CCO). This strategic hire follows the company’s most recent Management Buyout (MBO), initiating a new chapter of growth and expansion. In the newly created role, Nathalie will lead […]